R-spondin1, A Novel Intestinotrophic Mitogen, Ameliorates Experimental Colitis in Mice
- 1 April 2007
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 132 (4) , 1331-1343
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- R-spondin1 is essential in sex determination, skin differentiation and malignancyNature Genetics, 2006
- IL-23 is essential for T cell–mediated colitis and promotes inflammation via IL-17 and IL-6Journal of Clinical Investigation, 2006
- Blocking lymphotoxin-βreceptor activation diminishes inflammation via reduced mucosal addressin cell adhesion molecule-1 (MAdCAM-1) expression and leucocyte margination in chronic DSS-induced colitisClinical and Experimental Immunology, 2004
- The immunological and genetic basis of inflammatory bowel diseaseNature Reviews Immunology, 2003
- Antisense Oligonucleotide Blockade of Tumor Necrosis Factor-α in Two Murine Models of ColitisThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Pathway PathologyThe American Journal of Pathology, 2002
- Glucagon-like Peptide-2 Receptor Activation Engages Bad and Glycogen Synthase Kinase-3 in a Protein Kinase A-dependent Manner and Prevents Apoptosis following Inhibition of Phosphatidylinositol 3-KinaseJournal of Biological Chemistry, 2002
- Infliximab for the Treatment of Fistulas in Patients with Crohn's DiseaseNew England Journal of Medicine, 1999
- Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses.Journal of Clinical Investigation, 1996
- Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporinDigestive Diseases and Sciences, 1993